Advertisement
Singapore markets closed
  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • Dow

    38,503.69
    +263.71 (+0.69%)
     
  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     
  • Bitcoin USD

    66,063.84
    -45.59 (-0.07%)
     
  • CMC Crypto 200

    1,429.32
    +5.22 (+0.37%)
     
  • FTSE 100

    8,076.00
    +31.19 (+0.39%)
     
  • Gold

    2,337.20
    -4.90 (-0.21%)
     
  • Crude Oil

    82.97
    -0.39 (-0.47%)
     
  • 10-Yr Bond

    4.6440
    +0.0460 (+1.00%)
     
  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     
  • Jakarta Composite Index

    7,174.53
    +63.72 (+0.90%)
     
  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

FTSE posts worst weekly performance since January as U.S. healthcare vote looms

A worker shelters from the rain under a Union Flag umbrella as he passes the London Stock Exchange in London, Britain, October 1, 2008. REUTERS/Toby Melville/File Photo - RTSS1IU

By Kit Rees and Helen Reid

LONDON (Reuters) - Britain's top share index dipped on Friday ahead of a delayed U.S. vote on a key healthcare bill, though gains among Smiths Group (SMIN.L) and Provident Financial (PFG.L) capped losses.

The FTSE 100 (.FTSE) closed 0.1 percent lower. It had its worst weekly decline in two months, down 1.2 percent on the week. Global equity markets turned down on Tuesday as investors grew concerned about the 'Trump trade', which had been buoying stocks.

The healthcare vote has been seen by financial markets as a test of President Donald Trump's ability to work with Congress to deliver on his other priorities such as tax cuts and infrastructure spending, the promise of which have boosted shares since his election.

ADVERTISEMENT

Engineering firm Smiths Group (SMIN.L) was the top gainer, rising 3.3 percent and hitting a record high after posting higher first-half profit and maintaining its full-year outlook.

"Profits are almost 12 percent above our forecast (helped by R&D capitalisation) and guidance remains for a stronger 2H17. It is still arguably early days," Sandy Morris, equity analyst at Jefferies, said.

Shares in Provident Financial (PFG.L) were also among top gainers, up almost 2 percent after RBC raised its rating on the stock to "outperform" from "sector perform", citing the likelihood of consensus upgrades on expected increases in forward forecasts as well as "sector-leading" capital returns.

Retailers Next (.NXT.L) and M&S (MKS.L), top gainers in the previous session, were down 1.6 percent. UBS cut its target price on Next, saying it expected the retailer's underperformance to continue in the first quarter.

Overall gains were muted among blue chips as caution set in ahead of the vote on Trump's healthcare bill.

Trump and his fellow Republicans have pledged to scrap Obamacare, but have failed to close the deal on time for the planned Thursday vote.

"This is the first real hurdle (Trump) faces, and any resistance could suggest that (he) would face similar resistance to other policies down the road," Mike van Dulken, head of research at Accendo Markets, said.

"The current rally has gone so far on promises, the markets are starting to ask for a lot more proof."

So far the FTSE 100 has gained more than 7 percent since Trump won the U.S. presidential election, with stocks driven by a global reflation trade on hopes of increased fiscal spending and tax reforms.

Oil stocks were the biggest weights among the large caps, with BP (BP.L) and Royal Dutch Shell (RDSa.L) down 0.7 percent and 0.3 percent respectively.

(Reporting by Kit Rees; Editing by Gareth Jones)